/
/
A.
Thyroid and other radiation-related diseases in the exposed and
comparison populations.
B.
All of A plus other patients already taken into the study with
non-radiation related diseases (e.g., diabetes}.
This would include exposed and
comparison group patients only.
C.
All of A and B plus all low level radiation exposed patients who
have gone through full screening,
irrespective of findings of disease (e.g.,
the
Bikini group).
D.
on,
All of A, B, and C plus full screening of all inhabitants living
or scheduled to be repatriated to,
atomic fallout;
the Marshall Istinds contaminated by
i.e., background radiation higher than median for all
Micronesian islands.
* E.
Discontinue the study under DOE mandate and turn the care over to
the new Marshall Island Health Care System. *
With these five options in mind, we must first consider the common constraints impinging on the subheadings listed under Column II of the flow sheet
(see Figure 1}.
priate.
The unique constraints for each option will be listed as appro-
The common constraints are:
1.
Under current operating policies, DOE responsibilities do not
include health care for non-irradiation related pathologic conditions.
2.
not clear.
The defin:-ion of "radiation-related"” pathologic conditions is
There is uncertainty among radiation experts as to the biologic ef-
fects of long-term "low-level" radiation.
The status ~* acute and long-term ef-
fects of higher levels of radiation offers a greater consensus by the experts.
ORT ree ete a